0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cephalosporin Market Outlook 2022
Published Date: May 2019
|
Report Code: QYRE-Auto-16X255
Home | Market Reports | Business & Industrial | Pharmaceuticals & Biotech
Global Cephalosporin Market Insights Forecast to 2025

Global Cephalosporin Market Outlook 2022

Code: QYRE-Auto-16X255
Report
May 2019
123 Pages
QYResearch
Region: Global, China, India, Central & South America, North America, Middle East, Asia Pacific, Europe, Africa,
Description
Table of Content
Tables & Figures

Cephalosporin Market

The global Cephalosporin market was valued at USD 3914.3 Million in 2020 and is expected to reach USD 4465.6 Million by the end of 2027, growing at a CAGR of 1.9% during 2021-2027.

Cephalosporin is an antibiotic medication commonly prescribed to treat several different types of infections.

Cephalosporin originally derived from the fungus Acremonium, which was previously known as "Cephalosporium".

Market competition is intense. Union Chempharma, NCPC, Qilu Antibiotics, Lupin Pharmaceuticals and Hospira are the top 5 of Cephalosporin, with about 30% market shares.

China is the largest supplier of Cephalosporin, with a production market share nearly 43%. India is the second largest supplier of Cephalosporin, enjoying production market share nearly 22%.

Europe is the largest consumption place, with a consumption market share nearly 30%. Following Europe, North America is the second largest consumption place with the consumption market share of 25%.

The classification of Cephalosporin includes First Generation, Second Generation, Third Generation, Fourth Generation and the proportion of Third Generation is about 37%.

Cephalosporin is widely used in d Oral drugs and Injection drugs. The most proportion of Cephalosporin is Injection drugs, and the consumption proportion is about 55%.

This report focuses on Cephalosporin volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Cephalosporin market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

 The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

By Type

  • First Generation Cephalosporin
  • Second Generation Cephalosporin
  • Third Generation Cephalosporin
  • Fourth Generation Cephalosporin

By Application

  • Oral
  • Injection

By Region

  • North America
  • US.
  • Canada
  • Europe
  • Germany
  • France
  • UK.
  • Italy
  • Russia
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • Taiwan
  • Indonesia
  • Thailand
  • Malaysia
  • Philippines
  • Vietnam
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • U.A.E

By Company

  • Union Chempharma
  • NCPC
  • Qilu Antibiotics
  • Lupin Pharmaceuticals
  • Hospira
  • Dhanuka Laboratories
  • Fukang
  • Dongying Pharmaceutical
  • Alkem
  • SALUBRIS
  • LIVZON
  • Hetero Drugs
  • CSPC
  • TEVA
  • Orchid Pharma
  • Taj Pharmaceuticals
  • Covalent Laboratories
  • United Laboratories
  • Aurobindo
  • Wockhardt
  • LKPC
  • HPGC
  • Huafangpharm
1 Cephalosporin Market Overview
1.1 Product Overview and Scope of Cephalosporin
1.2 Cephalosporin Segment by Type
1.2.1 Global Cephalosporin Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 First Generation Cephalosporin
1.2.3 Second Generation Cephalosporin
1.2.4 Third Generation Cephalosporin
1.2.5 Fourth Generation Cephalosporin
1.3 Cephalosporin Segment by Application
1.3.1 Global Cephalosporin Sales Comparison by Application: (2021-2027)
1.3.2 Oral
1.3.3 Injection
1.4 Global Cephalosporin Market Size Estimates and Forecasts
1.4.1 Global Cephalosporin Revenue 2016-2027
1.4.2 Global Cephalosporin Sales 2016-2027
1.4.3 Cephalosporin Market Size by Region: 2016 Versus 2021 Versus 2027
2 Cephalosporin Market Competition by Manufacturers
2.1 Global Cephalosporin Sales Market Share by Manufacturers (2016-2021)
2.2 Global Cephalosporin Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Cephalosporin Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Cephalosporin Manufacturing Sites, Area Served, Product Type
2.5 Cephalosporin Market Competitive Situation and Trends
2.5.1 Cephalosporin Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Cephalosporin Players Market Share by Revenue
2.5.3 Global Cephalosporin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Cephalosporin Retrospective Market Scenario by Region
3.1 Global Cephalosporin Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Cephalosporin Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Cephalosporin Market Facts & Figures by Country
3.3.1 North America Cephalosporin Sales by Country
3.3.2 North America Cephalosporin Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Cephalosporin Market Facts & Figures by Country
3.4.1 Europe Cephalosporin Sales by Country
3.4.2 Europe Cephalosporin Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Cephalosporin Market Facts & Figures by Region
3.5.1 Asia Pacific Cephalosporin Sales by Region
3.5.2 Asia Pacific Cephalosporin Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Cephalosporin Market Facts & Figures by Country
3.6.1 Latin America Cephalosporin Sales by Country
3.6.2 Latin America Cephalosporin Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Cephalosporin Market Facts & Figures by Country
3.7.1 Middle East and Africa Cephalosporin Sales by Country
3.7.2 Middle East and Africa Cephalosporin Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Cephalosporin Historic Market Analysis by Type
4.1 Global Cephalosporin Sales Market Share by Type (2016-2021)
4.2 Global Cephalosporin Revenue Market Share by Type (2016-2021)
4.3 Global Cephalosporin Price by Type (2016-2021)
5 Global Cephalosporin Historic Market Analysis by Application
5.1 Global Cephalosporin Sales Market Share by Application (2016-2021)
5.2 Global Cephalosporin Revenue Market Share by Application (2016-2021)
5.3 Global Cephalosporin Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Union Chempharma
6.1.1 Union Chempharma Corporation Information
6.1.2 Union Chempharma Description and Business Overview
6.1.3 Union Chempharma Cephalosporin Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Union Chempharma Cephalosporin Product Portfolio
6.1.5 Union Chempharma Recent Developments/Updates
6.2 NCPC
6.2.1 NCPC Corporation Information
6.2.2 NCPC Description and Business Overview
6.2.3 NCPC Cephalosporin Sales, Revenue and Gross Margin (2016-2021)
6.2.4 NCPC Cephalosporin Product Portfolio
6.2.5 NCPC Recent Developments/Updates
6.3 Qilu Antibiotics
6.3.1 Qilu Antibiotics Corporation Information
6.3.2 Qilu Antibiotics Description and Business Overview
6.3.3 Qilu Antibiotics Cephalosporin Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Qilu Antibiotics Cephalosporin Product Portfolio
6.3.5 Qilu Antibiotics Recent Developments/Updates
6.4 Lupin Pharmaceuticals
6.4.1 Lupin Pharmaceuticals Corporation Information
6.4.2 Lupin Pharmaceuticals Description and Business Overview
6.4.3 Lupin Pharmaceuticals Cephalosporin Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Lupin Pharmaceuticals Cephalosporin Product Portfolio
6.4.5 Lupin Pharmaceuticals Recent Developments/Updates
6.5 Hospira
6.5.1 Hospira Corporation Information
6.5.2 Hospira Description and Business Overview
6.5.3 Hospira Cephalosporin Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Hospira Cephalosporin Product Portfolio
6.5.5 Hospira Recent Developments/Updates
6.6 Dhanuka Laboratories
6.6.1 Dhanuka Laboratories Corporation Information
6.6.2 Dhanuka Laboratories Description and Business Overview
6.6.3 Dhanuka Laboratories Cephalosporin Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Dhanuka Laboratories Cephalosporin Product Portfolio
6.6.5 Dhanuka Laboratories Recent Developments/Updates
6.7 Fukang
6.6.1 Fukang Corporation Information
6.6.2 Fukang Description and Business Overview
6.6.3 Fukang Cephalosporin Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Fukang Cephalosporin Product Portfolio
6.7.5 Fukang Recent Developments/Updates
6.8 Dongying Pharmaceutical
6.8.1 Dongying Pharmaceutical Corporation Information
6.8.2 Dongying Pharmaceutical Description and Business Overview
6.8.3 Dongying Pharmaceutical Cephalosporin Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Dongying Pharmaceutical Cephalosporin Product Portfolio
6.8.5 Dongying Pharmaceutical Recent Developments/Updates
6.9 Alkem
6.9.1 Alkem Corporation Information
6.9.2 Alkem Description and Business Overview
6.9.3 Alkem Cephalosporin Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Alkem Cephalosporin Product Portfolio
6.9.5 Alkem Recent Developments/Updates
6.10 SALUBRIS
6.10.1 SALUBRIS Corporation Information
6.10.2 SALUBRIS Description and Business Overview
6.10.3 SALUBRIS Cephalosporin Sales, Revenue and Gross Margin (2016-2021)
6.10.4 SALUBRIS Cephalosporin Product Portfolio
6.10.5 SALUBRIS Recent Developments/Updates
6.11 LIVZON
6.11.1 LIVZON Corporation Information
6.11.2 LIVZON Cephalosporin Description and Business Overview
6.11.3 LIVZON Cephalosporin Sales, Revenue and Gross Margin (2016-2021)
6.11.4 LIVZON Cephalosporin Product Portfolio
6.11.5 LIVZON Recent Developments/Updates
6.12 Hetero Drugs
6.12.1 Hetero Drugs Corporation Information
6.12.2 Hetero Drugs Cephalosporin Description and Business Overview
6.12.3 Hetero Drugs Cephalosporin Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Hetero Drugs Cephalosporin Product Portfolio
6.12.5 Hetero Drugs Recent Developments/Updates
6.13 CSPC
6.13.1 CSPC Corporation Information
6.13.2 CSPC Cephalosporin Description and Business Overview
6.13.3 CSPC Cephalosporin Sales, Revenue and Gross Margin (2016-2021)
6.13.4 CSPC Cephalosporin Product Portfolio
6.13.5 CSPC Recent Developments/Updates
6.14 TEVA
6.14.1 TEVA Corporation Information
6.14.2 TEVA Cephalosporin Description and Business Overview
6.14.3 TEVA Cephalosporin Sales, Revenue and Gross Margin (2016-2021)
6.14.4 TEVA Cephalosporin Product Portfolio
6.14.5 TEVA Recent Developments/Updates
6.15 Orchid Pharma
6.15.1 Orchid Pharma Corporation Information
6.15.2 Orchid Pharma Cephalosporin Description and Business Overview
6.15.3 Orchid Pharma Cephalosporin Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Orchid Pharma Cephalosporin Product Portfolio
6.15.5 Orchid Pharma Recent Developments/Updates
6.16 Taj Pharmaceuticals
6.16.1 Taj Pharmaceuticals Corporation Information
6.16.2 Taj Pharmaceuticals Cephalosporin Description and Business Overview
6.16.3 Taj Pharmaceuticals Cephalosporin Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Taj Pharmaceuticals Cephalosporin Product Portfolio
6.16.5 Taj Pharmaceuticals Recent Developments/Updates
6.17 Covalent Laboratories
6.17.1 Covalent Laboratories Corporation Information
6.17.2 Covalent Laboratories Cephalosporin Description and Business Overview
6.17.3 Covalent Laboratories Cephalosporin Sales, Revenue and Gross Margin (2016-2021)
6.17.4 Covalent Laboratories Cephalosporin Product Portfolio
6.17.5 Covalent Laboratories Recent Developments/Updates
6.18 United Laboratories
6.18.1 United Laboratories Corporation Information
6.18.2 United Laboratories Cephalosporin Description and Business Overview
6.18.3 United Laboratories Cephalosporin Sales, Revenue and Gross Margin (2016-2021)
6.18.4 United Laboratories Cephalosporin Product Portfolio
6.18.5 United Laboratories Recent Developments/Updates
6.19 Aurobindo
6.19.1 Aurobindo Corporation Information
6.19.2 Aurobindo Cephalosporin Description and Business Overview
6.19.3 Aurobindo Cephalosporin Sales, Revenue and Gross Margin (2016-2021)
6.19.4 Aurobindo Cephalosporin Product Portfolio
6.19.5 Aurobindo Recent Developments/Updates
6.20 Wockhardt
6.20.1 Wockhardt Corporation Information
6.20.2 Wockhardt Cephalosporin Description and Business Overview
6.20.3 Wockhardt Cephalosporin Sales, Revenue and Gross Margin (2016-2021)
6.20.4 Wockhardt Cephalosporin Product Portfolio
6.20.5 Wockhardt Recent Developments/Updates
6.21 LKPC
6.21.1 LKPC Corporation Information
6.21.2 LKPC Cephalosporin Description and Business Overview
6.21.3 LKPC Cephalosporin Sales, Revenue and Gross Margin (2016-2021)
6.21.4 LKPC Cephalosporin Product Portfolio
6.21.5 LKPC Recent Developments/Updates
6.22 HPGC
6.22.1 HPGC Corporation Information
6.22.2 HPGC Cephalosporin Description and Business Overview
6.22.3 HPGC Cephalosporin Sales, Revenue and Gross Margin (2016-2021)
6.22.4 HPGC Cephalosporin Product Portfolio
6.22.5 HPGC Recent Developments/Updates
6.23 Huafangpharm
6.23.1 Huafangpharm Corporation Information
6.23.2 Huafangpharm Cephalosporin Description and Business Overview
6.23.3 Huafangpharm Cephalosporin Sales, Revenue and Gross Margin (2016-2021)
6.23.4 Huafangpharm Cephalosporin Product Portfolio
6.23.5 Huafangpharm Recent Developments/Updates
7 Cephalosporin Manufacturing Cost Analysis
7.1 Cephalosporin Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Cephalosporin
7.4 Cephalosporin Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Cephalosporin Distributors List
8.3 Cephalosporin Customers
9 Cephalosporin Market Dynamics
9.1 Cephalosporin Industry Trends
9.2 Cephalosporin Growth Drivers
9.3 Cephalosporin Market Challenges
9.4 Cephalosporin Market Restraints
10 Global Market Forecast
10.1 Cephalosporin Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Cephalosporin by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Cephalosporin by Type (2022-2027)
10.2 Cephalosporin Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Cephalosporin by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Cephalosporin by Application (2022-2027)
10.3 Cephalosporin Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Cephalosporin by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Cephalosporin by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
    Table 1. Global Cephalosporin Sales (MT) Growth Rate Comparison by Type (2021-2027)
    Table 2. Global Cephalosporin Sales (MT) Comparison by Application (2021-2027)
    Table 3. Global Cephalosporin Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
    Table 4. Key Manufacturers Cephalosporin Covered in This Study
    Table 5. Global Cephalosporin Sales (MT) of Key Manufacturers (2016-2021)
    Table 6. Global Cephalosporin Sales Market Share by Manufacturers (2016-2021)
    Table 7. Global Cephalosporin Revenue (US$ Million) by Manufacturers (2016-2021)
    Table 8. Global Cephalosporin Revenue Share by Manufacturers (2016-2021)
    Table 9. Global Market Cephalosporin Average Price (USD/Kg) of Key Manufacturers (2016-2021)
    Table 10. Manufacturers Cephalosporin Manufacturing Sites and Area Served
    Table 11. Manufacturers Cephalosporin Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Cephalosporin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cephalosporin as of 2020)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Cephalosporin Sales by Region (2016-2021) & (MT)
    Table 16. Global Cephalosporin Sales Market Share by Region (2016-2021)
    Table 17. Global Cephalosporin Revenue by Region (2016-2021) & (US$ Million)
    Table 18. North America Cephalosporin Sales by Country (2016-2021) & (MT)
    Table 19. North America Cephalosporin Sales Market Share by Country (2016-2021)
    Table 20. North America Cephalosporin Revenue by Country (2016-2021) & (US$ Million)
    Table 21. North America Cephalosporin Revenue Market Share by Country (2016-2021)
    Table 22. Europe Cephalosporin Sales by Country (2016-2021) & (MT)
    Table 23. Europe Cephalosporin Sales Market Share by Country (2016-2021)
    Table 24. Europe Cephalosporin Revenue by Country (2016-2021) & (US$ Million)
    Table 25. Europe Cephalosporin Revenue Market Share by Country (2016-2021)
    Table 26. Asia Pacific Cephalosporin Sales by Region (2016-2021) & (MT)
    Table 27. Asia Pacific Cephalosporin Sales Market Share by Region (2016-2021)
    Table 28. Asia Pacific Cephalosporin Revenue by Region (2016-2021) & (US$ Million)
    Table 29. Asia Pacific Cephalosporin Revenue Market Share by Region (2016-2021)
    Table 30. Latin America Cephalosporin Sales by Country (2016-2021) & (MT)
    Table 31. Latin America Cephalosporin Sales Market Share by Country (2016-2021)
    Table 32. Latin America Cephalosporin Revenue by Country (2016-2021) & (US$ Million)
    Table 33. Latin America Cephalosporin Revenue Market Share by Country (2016-2021)
    Table 34. Middle East and Africa Cephalosporin Sales by Country (2016-2021) & (MT)
    Table 35. Middle East and Africa Cephalosporin Sales Market Share by Country (2016-2021)
    Table 36. Middle East and Africa Cephalosporin Revenue by Country (2016-2021) & (US$ Million)
    Table 37. Middle East and Africa Cephalosporin Revenue Market Share by Country (2016-2021)
    Table 38. Global Cephalosporin Sales (MT) by Type (2016-2021)
    Table 39. Global Cephalosporin Sales Market Share by Type (2016-2021)
    Table 40. Global Cephalosporin Revenue (Million US$) by Type (2016-2021)
    Table 41. Global Cephalosporin Revenue Share by Type (2016-2021)
    Table 42. Global Cephalosporin Price (USD/Kg) by Type (2016-2021)
    Table 43. Global Cephalosporin Sales (MT) by Application (2016-2021)
    Table 44. Global Cephalosporin Sales Market Share by Application (2016-2021)
    Table 45. Global Cephalosporin Revenue (Million US$) by Application (2016-2021)
    Table 46. Global Cephalosporin Revenue Share by Application (2016-2021)
    Table 47. Global Cephalosporin Price (USD/Kg) by Application (2016-2021)
    Table 48. Union Chempharma Corporation Information
    Table 49. Union Chempharma Description and Business Overview
    Table 50. Union Chempharma Cephalosporin Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
    Table 51. Union Chempharma Cephalosporin Product
    Table 52. Union Chempharma Recent Developments/Updates
    Table 53. NCPC Corporation Information
    Table 54. NCPC Description and Business Overview
    Table 55. NCPC Cephalosporin Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
    Table 56. NCPC Cephalosporin Product
    Table 57. NCPC Recent Developments/Updates
    Table 58. Qilu Antibiotics Corporation Information
    Table 59. Qilu Antibiotics Description and Business Overview
    Table 60. Qilu Antibiotics Cephalosporin Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
    Table 61. Qilu Antibiotics Cephalosporin Product
    Table 62. Qilu Antibiotics Recent Developments/Updates
    Table 63. Lupin Pharmaceuticals Corporation Information
    Table 64. Lupin Pharmaceuticals Description and Business Overview
    Table 65. Lupin Pharmaceuticals Cephalosporin Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
    Table 66. Lupin Pharmaceuticals Cephalosporin Product
    Table 67. Lupin Pharmaceuticals Recent Developments/Updates
    Table 68. Hospira Corporation Information
    Table 69. Hospira Description and Business Overview
    Table 70. Hospira Cephalosporin Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
    Table 71. Hospira Cephalosporin Product
    Table 72. Hospira Recent Developments/Updates
    Table 73. Dhanuka Laboratories Corporation Information
    Table 74. Dhanuka Laboratories Description and Business Overview
    Table 75. Dhanuka Laboratories Cephalosporin Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
    Table 76. Dhanuka Laboratories Cephalosporin Product
    Table 77. Dhanuka Laboratories Recent Developments/Updates
    Table 78. Fukang Corporation Information
    Table 79. Fukang Description and Business Overview
    Table 80. Fukang Cephalosporin Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
    Table 81. Fukang Cephalosporin Product
    Table 82. Fukang Recent Developments/Updates
    Table 83. Dongying Pharmaceutical Corporation Information
    Table 84. Dongying Pharmaceutical Description and Business Overview
    Table 85. Dongying Pharmaceutical Cephalosporin Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
    Table 86. Dongying Pharmaceutical Cephalosporin Product
    Table 87. Dongying Pharmaceutical Recent Developments/Updates
    Table 88. Alkem Corporation Information
    Table 89. Alkem Description and Business Overview
    Table 90. Alkem Cephalosporin Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
    Table 91. Alkem Cephalosporin Product
    Table 92. Alkem Recent Developments/Updates
    Table 93. SALUBRIS Corporation Information
    Table 94. SALUBRIS Description and Business Overview
    Table 95. SALUBRIS Cephalosporin Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
    Table 96. SALUBRIS Cephalosporin Product
    Table 97. SALUBRIS Recent Developments/Updates
    Table 98. LIVZON Corporation Information
    Table 99. LIVZON Description and Business Overview
    Table 100. LIVZON Cephalosporin Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
    Table 101. LIVZON Cephalosporin Product
    Table 102. LIVZON Recent Developments/Updates
    Table 103. Hetero Drugs Corporation Information
    Table 104. Hetero Drugs Description and Business Overview
    Table 105. Hetero Drugs Cephalosporin Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
    Table 106. Hetero Drugs Cephalosporin Product
    Table 107. Hetero Drugs Recent Developments/Updates
    Table 108. CSPC Corporation Information
    Table 109. CSPC Description and Business Overview
    Table 110. CSPC Cephalosporin Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
    Table 111. CSPC Cephalosporin Product
    Table 112. CSPC Recent Developments/Updates
    Table 113. TEVA Corporation Information
    Table 114. TEVA Description and Business Overview
    Table 115. TEVA Cephalosporin Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
    Table 116. TEVA Cephalosporin Product
    Table 117. TEVA Recent Developments/Updates
    Table 118. Orchid Pharma Corporation Information
    Table 119. Orchid Pharma Description and Business Overview
    Table 120. Orchid Pharma Cephalosporin Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
    Table 121. Orchid Pharma Cephalosporin Product
    Table 122. Orchid Pharma Recent Developments/Updates
    Table 123. Taj Pharmaceuticals Corporation Information
    Table 124. Taj Pharmaceuticals Description and Business Overview
    Table 125. Taj Pharmaceuticals Cephalosporin Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
    Table 126. Taj Pharmaceuticals Cephalosporin Product
    Table 127. Taj Pharmaceuticals Recent Developments/Updates
    Table 128. Covalent Laboratories Corporation Information
    Table 129. Covalent Laboratories Description and Business Overview
    Table 130. Covalent Laboratories Cephalosporin Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
    Table 131. Covalent Laboratories Cephalosporin Product
    Table 132. Covalent Laboratories Recent Developments/Updates
    Table 133. United Laboratories Corporation Information
    Table 134. United Laboratories Description and Business Overview
    Table 135. United Laboratories Cephalosporin Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
    Table 136. United Laboratories Cephalosporin Product
    Table 137. United Laboratories Recent Developments/Updates
    Table 138. Aurobindo Corporation Information
    Table 139. Aurobindo Description and Business Overview
    Table 140. Aurobindo Cephalosporin Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
    Table 141. Aurobindo Cephalosporin Product
    Table 142. Aurobindo Recent Developments/Updates
    Table 143. Wockhardt Corporation Information
    Table 144. Wockhardt Description and Business Overview
    Table 145. Wockhardt Cephalosporin Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
    Table 146. Wockhardt Cephalosporin Product
    Table 147. Wockhardt Recent Developments/Updates
    Table 148. LKPC Corporation Information
    Table 149. LKPC Description and Business Overview
    Table 150. LKPC Cephalosporin Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
    Table 151. LKPC Cephalosporin Product
    Table 152. LKPC Recent Developments/Updates
    Table 153. HPGC Corporation Information
    Table 154. HPGC Description and Business Overview
    Table 155. HPGC Cephalosporin Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
    Table 156. HPGC Cephalosporin Product
    Table 157. HPGC Recent Developments/Updates
    Table 158. Huafangpharm Corporation Information
    Table 159. Huafangpharm Description and Business Overview
    Table 160. Huafangpharm Cephalosporin Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
    Table 161. Huafangpharm Cephalosporin Product
    Table 162. Huafangpharm Recent Developments/Updates
    Table 163. Production Base and Market Concentration Rate of Raw Material
    Table 164. Key Suppliers of Raw Materials
    Table 165. Cephalosporin Distributors List
    Table 166. Cephalosporin Customers List
    Table 167. Cephalosporin Market Trends
    Table 168. Cephalosporin Growth Drivers
    Table 169. Cephalosporin Market Challenges
    Table 170. Cephalosporin Market Restraints
    Table 171. Global Cephalosporin Sales Forecast by Type (2022-2027) & (MT)
    Table 172. Global Cephalosporin Sales Market Share Forecast by Type (2022-2027)
    Table 173. Global Cephalosporin Revenue Forecast by Type (2022-2027) & (US$ Million)
    Table 174. Global Cephalosporin Revenue Market Share Forecast by Type (2022-2027)
    Table 175. Global Cephalosporin Sales Forecast by Application (2022-2027) & (MT)
    Table 176. Global Cephalosporin Sales Market Share Forecast by Application (2022-2027)
    Table 177. Global Cephalosporin Revenue Forecast by Application (2022-2027) & (US$ Million)
    Table 178. Global Cephalosporin Revenue Market Share Forecast by Application (2022-2027)
    Table 179. Global Cephalosporin Sales Forecast by Region (2022-2027) & (MT)
    Table 180. Global Cephalosporin Sales Market Share Forecast by Region (2022-2027)
    Table 181. Global Cephalosporin Revenue Forecast by Region (2022-2027) & (US$ Million)
    Table 182. Global Cephalosporin Revenue Market Share Forecast by Region (2022-2027)
    Table 183. Research Programs/Design for This Report
    Table 184. Key Data Information from Secondary Sources
    Table 185. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Cephalosporin
    Figure 2. Global Cephalosporin Market Share by Type in 2020 & 2027
    Figure 3. First Generation Cephalosporin Product Picture
    Figure 4. Second Generation Cephalosporin Product Picture
    Figure 5. Third Generation Cephalosporin Product Picture
    Figure 6. Fourth Generation Cephalosporin Product Picture
    Figure 7. Global Cephalosporin Market Share by Application in 2020 & 2027
    Figure 8. Oral
    Figure 9. Injection
    Figure 10. Global Cephalosporin Revenue, (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global Cephalosporin Market Size 2016-2027 (US$ Million)
    Figure 12. Global Cephalosporin Sales 2016-2027 (MT)
    Figure 13. Global Cephalosporin Market Size Market Share by Region: 2016 VS 20210 VS 2027
    Figure 14. Cephalosporin Sales Share by Manufacturers in 2020
    Figure 15. Global Cephalosporin Revenue Share by Manufacturers in 2020
    Figure 16. The Global 5 and 10 Largest Cephalosporin Players: Market Share by Revenue in 2020
    Figure 17. Cephalosporin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
    Figure 18. Global Cephalosporin Sales Market Share by Region (2016-2021)
    Figure 19. Global Cephalosporin Sales Market Share by Region in 2020
    Figure 20. Global Cephalosporin Revenue Market Share by Region (2016-2021)
    Figure 21. Global Cephalosporin Revenue Market Share by Region in 2020
    Figure 22. U.S. Cephalosporin Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 23. Canada Cephalosporin Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 24. Germany Cephalosporin Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 25. France Cephalosporin Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 26. U.K. Cephalosporin Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 27. Italy Cephalosporin Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 28. Russia Cephalosporin Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 29. China Cephalosporin Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 30. Japan Cephalosporin Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 31. South Korea Cephalosporin Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 32. India Cephalosporin Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 33. Australia Cephalosporin Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 34. Taiwan Cephalosporin Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 35. Indonesia Cephalosporin Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 36. Thailand Cephalosporin Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 37. Malaysia Cephalosporin Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 38. Philippines Cephalosporin Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 39. Vietnam Cephalosporin Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 40. Mexico Cephalosporin Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 41. Brazil Cephalosporin Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 42. Argentina Cephalosporin Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 43. Turkey Cephalosporin Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 44. Saudi Arabia Cephalosporin Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 45. U.A.E Cephalosporin Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 46. Sales Market Share of Cephalosporin by Type (2016-2021)
    Figure 47. Sales Market Share of Cephalosporin by Application (2016-2021)
    Figure 48. Sales Market Share of Cephalosporin by Application in 2020
    Figure 49. Revenue Share of Cephalosporin by Application (2016-2021)
    Figure 50. Revenue Share of Cephalosporin by Application in 2020
    Figure 51. Manufacturing Cost Structure of Cephalosporin
    Figure 52. Manufacturing Process Analysis of Cephalosporin
    Figure 53. Cephalosporin Industrial Chain Analysis
    Figure 54. Channels of Distribution
    Figure 55. Distributors Profiles
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation
    Figure 58. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$2900
This license allows only one user(purchaser of the report) to access the PDF.

Electronic (PDF)
$4350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$5800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
SIS Group of Schools

RELATED REPORTS

Global Torasemide API Market Research Report 2022
Global Torasemide API Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-37B11450
Fri Aug 12 00:00:00 UTC 2022

Add to Cart

Global Baloxavir Marboxil API Market Research Report 2022
Global Baloxavir Marboxil API Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-39E11527
Fri Aug 12 00:00:00 UTC 2022

Add to Cart

Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Research Report 2022
Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-29D11405
Fri Aug 12 00:00:00 UTC 2022

Add to Cart

Global Chemiluminescence Immunodiagnostic Market Research Report 2022
Global Chemiluminescence Immunodiagnostic Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-18X11631
Fri Aug 12 00:00:00 UTC 2022

Add to Cart